Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • COX
    (2)
  • Cannabinoid Receptor
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Inflammation
    (2)
  • Immune System
    (1)
Filter
Search Result
Results for "

rofecoxib

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
Rofecoxib
MK-0966, MK 966
T1185162011-90-7
Rofecoxib (MK 966) binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in an inhibition of the conversion of arachidonic acid to prostaglandins. Rofecoxib is a synthetic, nonsteroidal derivative of phenyl-furanone with anti-inflammatory, antipyretic and analgesic properties and potential antineoplastic properties. COX-related metabolic pathways may represent key regulators of cell proliferation and neo-angiogenesis. Some epithelial tumor cell types overexpress pro-angiogenic COX-2.
  • $30
In Stock
Size
QTY
Rofecoxib-[D5] (Standard)
TMSM-6406544684-93-7
Rofecoxib-[D5] (Standard) is a reference standard of Rofecoxib-[D5] intended for quantitative analysis, quality control, and related biochemical research applications.
  • $898
4-6 weeks
Size
QTY
Parecoxib sodium
SC-69124A, SC69124A, SC 69124A, Dynastat
T1780L198470-85-8
Parecoxib sodium is a prodrug of Valdecoxib and a selective, orally active COX-2 inhibitor that suppresses prostaglandin (PG) synthesis and alleviates pain and inflammation. Parecoxib sodium also acts as a cannabinoid 1 (CB1) receptor agonist (EC50=2.4 µM).
  • $30
7-10 days
Size
QTY